The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

The 2020 Focused Updates to the Asthma Management Guidelines: A Report from the
National Asthma Education and Prevention Program Coordinating Committee Expert Panel …

Background There is no proven specific pharmacological treatment for patients with the
acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS …

Background In double-blind, placebo-controlled trials, budesonide–formoterol used on an
as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed …

Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …

This review focuses on recent clinical and translational discoveries in severe and
uncontrolled asthma that now enable phenotyping and personalized therapies in these …

The 2020 National Asthma Education and Prevention Program Coordinating Committee
Expert Panel Working Group (NAEPP [2020 Focused Asthma Update]) guidelines and the …

Asthma is a chronic disease principally characterized by episodic wheeze, cough, and
breathlessness resulting from airway hyperresponsiveness and inflammation. It is one of the …

Acute asthma remains an important medical emergency, the most frequent cause of acute
admissions in children and a major source of morbidity for adults with asthma. In all ages …

Oral corticosteroids (OCS) are frequently used for asthma treatment. This medication is
highly effective for both acute and chronic diseases, but evidence indicates that …